Pre-Clinical validation of Eyful’s solution providing general visual enhancements for AMD patients using augmented reality

Founded in 2019 in Montreal, Eyful is a young start-up at the juncture of technology and medicine. Our mission is to help people with retinal diseases regain their independence by enhancing and assisting their vision. More specifically, we have been working for the past two-years on assisting patients suffering from aged- related macular degeneration (AMD), using artificial intelligence (AI) and augmented reality (AR).

We have developed in-house algorithms predicting the visual symptoms of a patient diagnosed with AMD, as well corrections to help them see better, using AR. With the help of patients, we need to validate that our predictions are accurate and that our corrections are helpful in a systematic and replicable manner. To this end, we have partnered with an optometric clinic, and have prepared a pre-clinical trial. This trial will be the focus of this Mitacs project.

Faculty Supervisor:

Luc Duong

Student:

Partner:

eyful Inc.

Discipline:

Engineering

Sector:

Manufacturing

University:

École de technologie supérieure

Program: